0001209191-22-042485.txt : 20220718
0001209191-22-042485.hdr.sgml : 20220718
20220718192911
ACCESSION NUMBER: 0001209191-22-042485
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20220718
DATE AS OF CHANGE: 20220718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luderer Albert
CENTRAL INDEX KEY: 0001746822
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38613
FILM NUMBER: 221090116
MAIL ADDRESS:
STREET 1: C/O BIONANO
STREET 2: 9640 TOWNE CENTRE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bionano Genomics, Inc.
CENTRAL INDEX KEY: 0001411690
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 261756290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9540 TOWNE CENTRE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 888-7600
MAIL ADDRESS:
STREET 1: 9540 TOWNE CENTRE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Bionano Genomics, Inc
DATE OF NAME CHANGE: 20190308
FORMER COMPANY:
FORMER CONFORMED NAME: BioNano Genomics, Inc
DATE OF NAME CHANGE: 20120703
FORMER COMPANY:
FORMER CONFORMED NAME: BioNanomatrix Inc
DATE OF NAME CHANGE: 20070906
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2020-06-30
2020-07-02
0
0001411690
Bionano Genomics, Inc.
BNGO
0001746822
Luderer Albert
C/O BIONANO GENOMICS, INC.
9540 TOWNE CENTRE DRIVE, SUITE 100
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
0.51
2020-06-30
4
A
0
44470
0.00
A
2030-06-30
Common Stock
44470
44470
D
The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).
The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029.
/s/ R. Erik Holmlin, Attorney-in-Fact
2022-07-18